May 17, 2017 21:00 pm UTC| Business
– Company to Host Conference Call and Webcast on Sunday, June 4th at 5:30PMCT – STAMFORD, Conn., May 17, 2017 -- Loxo Oncology, Inc.(Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly...
May 17, 2017 20:59 pm UTC| Business
ORLANDO, Fla., May 17, 2017 -- The life settlement marketplace is poised for new growth opportunities as industry participants better leverage emerging technologies to facilitate the sale of seniors’ life insurance...
May 17, 2017 20:59 pm UTC| Business
ORLANDO, Fla., May 17, 2017 -- The life settlement marketplace is poised for new growth opportunities as industry participants better leverage emerging technologies to facilitate the sale of seniors’ life insurance...
Repros Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock
May 17, 2017 20:55 pm UTC| Business
THE WOODLANDS, Texas, May 17, 2017 -- Repros Therapeutics Inc. (Nasdaq:RPRX) (“Repros” or the “Company”) today announced that it intends to offer primary shares of its common stock and warrants to purchase shares of its...
Galaxy Gaming Reports Q1 2017 Financial Results
May 17, 2017 20:51 pm UTC| Business
LAS VEGAS, May 17, 2017 -- Galaxy Gaming, Inc. (OTCQB:GLXZ), the world's largest independent developer, manufacturer and distributor of casino table games and enhanced systems, announced today its results for the...
Cenovus completes acquisition of assets in Western Canada from ConocoPhillips
May 17, 2017 20:35 pm UTC| Business
CALGARY, Alberta, May 17, 2017 -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) has closed its previously announced purchase of assets in Western Canada from ConocoPhillips after receiving all necessary regulatory approvals...
New Clinical and Biomarker Data Validate Immune Design’s Lead Programs and Discovery Platforms
May 17, 2017 20:35 pm UTC| Business
Data from CMB305 and G100 to be Presented at ASCO Annual Meeting in June 2017 SEATTLE and SOUTH SAN FRANCISCO, May 17, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology,...